INDOLENT LYMPHOMA

Clinical trials for INDOLENT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INDOLENT LYMPHOMA trials appear

Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 1 Terminated 1

Off-the-Shelf cell therapy takes on tough blood cancers

Disease control Ongoing

This early-stage trial is testing an experimental therapy called NKX019 for people with certain blood cancers (like lymphoma and leukemia) that have come back or not responded to standard treatments. NKX019 uses donor immune cells (natural killer cells) that are engineered to fin…

Matched conditions: INDOLENT LYMPHOMA

Phase: PHASE1 • Sponsor: Nkarta, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

INDOLENT LYMPHOMA

Get alerted when new INDOLENT LYMPHOMA trials appear

Off-the-Shelf cell therapy takes on tough blood cancers